INVALID XLV

0 shares at $152.92 on 2026-06-16

Reasoning

[SKIPPED: intent trim_to_portfolio_pct resolved to 0 shares against held=1.937358734] CONTINUATION of June 15 defensive trim (Decision #82, Playbook #129). XLV was trimmed 40% yesterday as the Iran-deal resolution and oil stabilization ($77, down ~5% from $82) unwound the real-yield-repricing regime that justified the June 9 entry. NEW EVIDENCE TODAY: The rotation has BROADENED further — Dow at record highs, financials +1.3% (5d), cyclicals leading broadly, while defensive bid fades (XLV down 0.7% today, QQQ +3.08%, tech +3.7%). The macro driver (inflation/real-yield tail risk) that made healthcare a hedge has materially diminished. Thesis #58 (defensive rotation) remains low-conviction; its underlying premise (flight-to-safety from rate repricing) is now decayed. Trim the residual position to ~3% of portfolio (~$3,000 at current $99.8k equity) to free ~$1,200 dry powder for post-FOMC rotation beneficiaries (XLF/XLI). HOLD residual (do not full-exit) because: (1) FOMC is binary tomorrow and a hawkish-surprise repricing could re-arm the defensive sleeve; (2) Iran deal is unsigned until Friday Burgenstock signing and Israel has not endorsed — a collapse re-arms Rule #2 (geopolitical oil shock). Residual hedge coverage is warranted against both binary outcomes. This is NOT a reversal of the June 15 trim; it is a continuation of the same regime-shift logic with fresh intraday tape confirmation.

Thesis

XLV healthcare ETF — wind-down COMPLETION (supervisor item 70: exit incomplete since June 19). The managed-exit decision stands even though healthcare is leading today's tape (+1.8% 1d): the defensive sleeve is already covered by higher-conviction single names (LLY, MRK) plus XLP ballast, making the ETF wrapper redundant, and the sleeve's own terms state full exit is acceptable on any session with adequate liquidity. Eight weeks of incomplete wind-down is a resolution failure, not a re-validation — finish the exit rather than flip-flop the lowest-conviction wrapper back to a hold on one strong session. (long, low confidence)

Cited evidence

Macro